The mechanisms by which EMPA prevents diabetes are weight loss, changes in inflammatory markers, and reduction in insulin resistance (IR) and insulin amount. The conversion of white adipocyte tissue (WAT) to brown adipocyte tissue (BAT) via a mechanism called the browning process is a major target for obesity prevention. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.